Myomo Inc. logo

Myomo Inc. (MYO)

Market Closed
5 Dec, 20:00
AMEX AMEX
$
1. 04
+0.02
+1.96%
$
117.88M Market Cap
- P/E Ratio
0% Div Yield
881,900 Volume
- Eps
$ 1.02
Previous Close
Day Range
1 1.05
Year Range
0.71 7.17
Want to track MYO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MYO closed yesterday higher at $1.04, an increase of 1.96% from Thursday's close, completing a monthly increase of 9.47% or $0.09. Over the past 12 months, MYO stock lost -83.7%.
MYO is not paying dividends to its shareholders.
The last earnings report, released on Nov 10, 2025, exceeded the consensus estimates by 0.02%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports.
Myomo Inc. has completed 1 stock splits, with the recent split occurring on Jan 31, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on AMEX (USD).

MYO Chart

Similar

Armata Pharmaceuticals Inc.
$ 5.63
-5.22%
Senseonics Holdings, Inc.
$ 6.62
-1.63%
Electromed Inc.
$ 27.81
+0.04%
Perspective Therapeutics Inc.
$ 2.4
+0.42%
PLX
Protalix Biotherapeutics Inc.
$ 1.73
-1.14%
Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript

Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript

Myomo, Inc. ( MYO ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Paul Gudonis - President, CEO & Chairman David Henry - Chief Financial Officer Conference Call Participants Tirth Patel Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Anthony Vendetti - Maxim Group LLC, Research Division Xun Lee - H.C. Wainwright & Co, LLC, Research Division Edward Woo - Ascendiant Capital Markets LLC, Research Division Presentation Operator Good day, and welcome to the Myomo Third Quarter 2025 Financial Results Conference Call.

Seekingalpha | 3 weeks ago
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.03 per share a year ago.

Zacks | 3 weeks ago
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) came out with a quarterly loss of $0.11 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.

Zacks | 3 months ago

Myomo Inc. (MYO) FAQ

What is the stock price today?

The current price is $1.04.

On which exchange is it traded?

Myomo Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is MYO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 117.88M.

Has Myomo Inc. ever had a stock split?

Myomo Inc. had 1 splits and the recent split was on Jan 31, 2020.

Myomo Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Paul R. Gudonis CEO
AMEX Exchange
US62857J2015 ISIN
United States Country
101 Employees
- Last Dividend
31 Jan 2020 Last Split
- IPO Date

Overview

Myomo, Inc. operates within the forefront of wearable medical robotics, centered on conceiving, developing, and manufacturing myoelectric orthotics specifically designed for individuals afflicted by neuromuscular disorders. The company's operational footprint extends across the United States, China, Germany, and various international markets. Since its establishment in 2004, Myomo has been dedicated to improving the quality of life for people dealing with the consequences of neuromuscular conditions. With its headquarters nestled in Boston, Massachusetts, Myomo, Inc. has been a beacon of innovation, empowering adults and adolescents facing challenges from brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, among other neurological disorders, to regain function and independence in their daily activities.

Products and Services

  • MyoPro
  • Marketed as a myoelectric-controlled upper limb brace, or orthosis, MyoPro stands out as Myomo's flagship product designed to assist patients whose arms have become weak or paralyzed. This innovative device enables users to carry out functional daily living activities by providing the necessary support to the affected limb. By harnessing myoelectric signals from the user's muscle movements, MyoPro facilitates greater arm mobility and function, embodying a leap forward in assistive technology.

  • MyoPro 2
  • Building upon the foundational technology of its predecessor, MyoPro 2 integrates advanced control technology, configuration software, and user interface enhancements. A significant feature of MyoPro 2 is the inclusion of a pop-out battery, which extends the device's usage time, thereby promoting longer periods of independence and activity without necessitating frequent recharging.

  • MyoPro2+
  • Representing the pinnacle of Myomo's technological advancements, MyoPro2+ encompasses a series of improvements over the MyoPro 2. This iteration introduces 3D printed orthotics capabilities, further software enhancements, and a redesigned interface for easier donning and doffing of the device. The MyoPro2+ caters directly to the user's need for a more personalized and comfortable fit, coupled with increased efficiency and user-friendliness, making it a premier solution for those seeking to overcome upper limb paralysis or weakness.

Myomo’s distribution strategy traverses a wide spectrum of sales channels, including partnerships with orthotics and prosthetics providers, collaborations with the Veterans Administration, and an extensive network of distributors. This multifaceted approach ensures that Myomo's groundbreaking products are accessible to a broad audience, including those who might benefit the most from wearable medical robotics technologies.

Contact Information

Address: 137 Portland Street
Phone: 617-996-9058